SCHEMBL14083298

SCHEMBL14083298

CCN(CC)c1ccc(NC(=O)c2ccc(-c3ncccc3OC)c(OC)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 1/20 0.54
▸ MAPT P10636 7/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.53
▸ GFER P55789 2/20 0.53
▸ ALDH1A1 P00352 7/20 0.53
▸ LMNA P02545 4/20 0.53
▸ MAPK1 P28482 3/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ KMT2A Q03164 5/20 0.53
▸ MEN1 O00255 4/20 0.53
▸ HTT P42858 2/20 0.52
▸ GAA P10253 1/20 0.52
▸ AURKB Q96GD4 1/20 0.51
▸ MCL1 Q07820 2/20 0.48
▸ NPC1 O15118 3/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083374 0.92 MAPT (0.53) GHSRMAPTNPSR1GFERALDH1A1
SCHEMBL14083094 0.92 MAPT (0.49) GHSRMAPTNPSR1GFERALDH1A1
SCHEMBL14083771 0.91 ALDH1A1 (0.54) GHSRMAPTNPSR1GFERALDH1A1
SCHEMBL14083065 0.88 TRPV1 (0.60) GHSRMAPTNPSR1GFERALDH1A1
SCHEMBL14083121 0.87 TRPV1 (0.60) GHSRMAPTNPSR1GFERALDH1A1
SCHEMBL14083297 0.86 MEN1 (0.58) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL14083301 0.85 AURKB (0.57) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL14083307 0.84 TRPV1 (0.52) MAPTALDH1A1LMNAAURKBNPC1
SCHEMBL14083319 0.84 ALDH1A1 (0.54) MAPTNPSR1ALDH1A1LMNAMAPK1
SCHEMBL14083306 0.83 TRPV1 (0.58) MAPTALDH1A1LMNAMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 GHSR 3334/4885MAPT 2822/4885NPSR1 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback